Our understanding of stem cells has improved exponentially since their discovery, transforming our treatment of hematological malignancies and other diseases. Here, Irving Weissman, MD, of the Stanford University School of Medicine, Stanford, CA, discusses the use of stem cell transplantation and gives his perspective on their usage thus far. This interview was recorded at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.
Normal and neoplastic stem cells: from discovery to treatments
